感染鲍曼不动杆菌分离株的裂解性噬菌体LZ35的全基因组序列
Complete Genome Sequence of Lytic Bacteriophage LZ35 Infecting Acinetobacter baumannii Isolates.
作者信息
Guo Zhonghe, Huang Honglan, Wu Xiaolin, Hao Yuchong, Sun Yanbo
机构信息
Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun, People's Republic of China.
Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun, People's Republic of China
出版信息
Genome Announc. 2016 Nov 17;4(6):e01104-16. doi: 10.1128/genomeA.01104-16.
Abstract
Acinetobacter baumannii is a Gram-negative opportunistic pathogen that is frequently associated with nosocomial infections. Bacteriophages infecting A. baumannii can be used as effective agents to control these infections. Here, we announce the complete genome sequence of the lytic bacteriophage LZ35 infecting A. baumannii isolates.
摘要
鲍曼不动杆菌是一种革兰氏阴性机会致病菌，常与医院感染相关。感染鲍曼不动杆菌的噬菌体可作为控制这些感染的有效制剂。在此，我们公布了感染鲍曼不动杆菌分离株的裂解性噬菌体LZ35的完整基因组序列。
相似文献
1
Complete Genome Sequence of Lytic Bacteriophage LZ35 Infecting Acinetobacter baumannii Isolates.
Genome Announc. 2016 Nov 17;4(6):e01104-16. doi: 10.1128/genomeA.01104-16.
2
Characterization and complete genome sequence analysis of two Myoviral bacteriophages infecting clinical carbapenem-resistant Acinetobacter baumannii isolates.
J Appl Microbiol. 2016 Jul;121(1):68-77. doi: 10.1111/jam.13134.
3
Investigating Bacteriophages Targeting the Opportunistic Pathogen .
Antibiotics (Basel). 2020 Apr 22;9(4):200. doi: 10.3390/antibiotics9040200.
4
Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
BMC Microbiol. 2019 Apr 2;19(1):70. doi: 10.1186/s12866-019-1443-5.
5
Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii.
FEMS Microbiol Lett. 2012 Jul;332(1):40-6. doi: 10.1111/j.1574-6968.2012.02573.x. Epub 2012 May 8.
6
Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro.
Future Microbiol. 2016 Oct;11:1383-1393. doi: 10.2217/fmb-2016-0104. Epub 2016 Aug 18.
7
Complete Genome Sequence of the Lytic Bacteriophage Phab24, Which Infects Clinical Strains of the Nosocomial Pathogen Acinetobacter baumannii.
Microbiol Resour Announc. 2021 Oct 7;10(40):e0066921. doi: 10.1128/MRA.00669-21.
8
Genomic analysis of bacteriophage ϕAB1, a ϕKMV-like virus infecting multidrug-resistant Acinetobacter baumannii.
Genomics. 2011 Apr;97(4):249-55. doi: 10.1016/j.ygeno.2011.01.002. Epub 2011 Jan 15.
9
Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant in Mice.
Front Microbiol. 2018 Jan 9;8:2659. doi: 10.3389/fmicb.2017.02659. eCollection 2017.
10
Novel lytic bacteriophage AB7-IBB1 of Acinetobacter baumannii: isolation, characterization and its effect on biofilm.
Arch Virol. 2012 Aug;157(8):1441-50. doi: 10.1007/s00705-012-1320-0. Epub 2012 May 3.
引用本文的文献
1
Lytic Capsule-Specific Bacteriophages Encoding Polysaccharide-Degrading Enzymes.
Viruses. 2024 May 13;16(5):771. doi: 10.3390/v16050771.
2
New Phages Brutus and Scipio: Biology, Evolution, and Phage-Host Interaction.
Int J Mol Sci. 2024 Feb 8;25(4):2074. doi: 10.3390/ijms25042074.
3
Potential Usefulness of Bacteriophages for the Treatment of Multidrug-Resistant Infection.
Malays J Med Sci. 2023 Oct;30(5):7-22. doi: 10.21315/mjms2023.30.5.2. Epub 2023 Oct 30.
4
Comparative Analysis of 37 Bacteriophages.
Viruses. 2017 Dec 24;10(1):5. doi: 10.3390/v10010005.
本文引用的文献
1
Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates.
BMC Microbiol. 2014 Jul 5;14:181. doi: 10.1186/1471-2180-14-181.
2
Phage therapy gets revitalized.
Nature. 2014 Jun 5;510(7503):15-6. doi: 10.1038/510015a.
3
The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST).
Nucleic Acids Res. 2014 Jan;42(Database issue):D206-14. doi: 10.1093/nar/gkt1226. Epub 2013 Nov 29.
4
Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
J Pharm Pharmacol. 2011 Oct;63(10):1253-64. doi: 10.1111/j.2042-7158.2011.01324.x. Epub 2011 Jul 6.
5
Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections.
Virulence. 2011 Mar-Apr;2(2):97-102. doi: 10.4161/viru.2.2.15061. Epub 2011 Mar 1.
6
Acinetobacter baumannii: emergence of a successful pathogen.
Clin Microbiol Rev. 2008 Jul;21(3):538-82. doi: 10.1128/CMR.00058-07.
7
Global challenge of multidrug-resistant Acinetobacter baumannii.
Antimicrob Agents Chemother. 2007 Oct;51(10):3471-84. doi: 10.1128/AAC.01464-06. Epub 2007 Jul 23.
Zotero 插件